Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase 1/2 clinical study of OTO-413 in hearing loss patients.

Trial Profile

A phase 1/2 clinical study of OTO-413 in hearing loss patients.

Planning
Phase of Trial: Phase I/II

Latest Information Update: 03 Jan 2019

At a glance

  • Drugs OTO-413 (Primary)
  • Indications Sensorineural hearing loss
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 03 Jan 2019 According to an Otonomy media release, the trial is expected to start in the third quarter of 2019 with results in the second half of 2020.
    • 08 Mar 2018 According to an Otonomy media release, the trial expected to begin in the first half of 2019.
    • 12 Feb 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top